Earnings Feed
Start Free
BridgeBio Pharma, Inc.·4

Dec 31, 5:52 PM ET

Satvat Ali J. 4

4 · BridgeBio Pharma, Inc. · Filed Dec 31, 2024

Insider Transaction Report

Form 4
Period: 2024-12-30
BridgeBio Pharma, Inc.BBIO
Satvat Ali J.
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2024-12-30$16.68/sh+39,851$664,715→ 119,553 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-12-30−39,851→ 0 total
    Exercise: $16.68Exp: 2029-06-12→ Common Stock (39,851 underlying)
  • Exercise/Conversion

    Common Stock

    2024-12-30$26.21/sh+39,851$1,044,495→ 159,404 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-12-30−39,851→ 0 total
    Exercise: $26.21Exp: 2030-05-27→ Common Stock (39,851 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-12-30−79,702→ 0 total
    Exercise: $10.99Exp: 2028-07-01→ Common Stock (79,702 underlying)
  • Exercise/Conversion

    Common Stock

    2024-12-30$10.99/sh+79,702$875,925→ 79,702 total
Footnotes (1)
  • [F1]The stock option was fully vested and exercisable on the date of issuance by the Issuer as of January 26, 2021.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4